Skip to content
stockmarketcap
Discover
Top gainersTop losersMost activeMarket sectorsHeatmapTreasury rates
Earnings calendarIPO calendarEx-dividend calendarEconomic calendar
Congress tradesInsider tradesAnalyst upgrades & downgrades
Collections
ScreenerCompareBacktester
ValuationFundamentals
WatchlistPortfolioPricing
Sign in
Markets
StocksGainersLosersMost activeMarket sectorsHeatmapEarnings calendarCongress tradesInsider tradesAnalyst upgrades/downgradesIPO calendarEx-dividend calendar
Tools
ScreenerCompare stocksReturns backtesterPortfolio trackerWatchlistEmbeddable widget
Metrics
ValuationFundamentals
Popular lists
Best dividend stocksBest value stocksLargest companiesLowest P/E stocks
Collections
All lists & collectionsUS stocksJapanese stocksChinese stocksHong Kong stocksSouth Korean stocksTaiwanese stocksCanadian stocksUK stocksEuropean stocksMagnificent 7AI stocksSemiconductor stocks
Compare
Compare stocksFinviz alternativeKoyfin alternativeTradingView alternativeStockAnalysis alternative
Learn
Investing glossaryHelp & guide
StockMarketCapDocsTokenTermsPrivacyData for information only, not investment advice.
◆

ABT vs MRK

Abbott Laboratories and Merck & Co., Inc. compared side by side. Customize this comparison

Performance (normalized)

-31%-5%+20%+45%+70%stockmarketcap.io

Key metrics

MetricABT logoABTMRK logoMRK
Price$95.63$126.78
Market cap$166.57B$313.12B
P/E ratio (TTM)25.19x36.07x
P/S ratio (TTM)3.50x4.84x
Dividend yield2.69%2.62%
Beta0.620.22
1-year return-28.47%+56.71%

Want return correlation and up to five stocks side by side? The advanced compare tool is part of Plus.